Surface Ig (sIg) of follicular lymphoma (FL) is vital for tumor cell survival. We found previously that the Ig in FL is unusual, because the variable region genes carry sequence motifs for N-glycan addition. These are introduced by somatic mutation and are tumor specific. Unexpectedly, added glycans terminate at high mannose, suggesting a potentially important interaction of FL cells with mannose-binding lectins of the innate immune system. We have now identified mannosylated IgM at the surface of primary lymphoma cells. Recombinant lectin domains of the mannose receptor (MR) or DC-SIGN bind mannosylated Igs in vitro and bind to FL cells, signaling sIgM-associated increases in intracellular Ca 2+ . Lectins also bind to normal B cells but fail to signal. In contrast, anti-Ig signaled similarly in both FL and normal B cells. Mannosylation patterns were mimicked by FL Ig-derived single-chain Fvs (scFv), providing probes for potential receptors. Mannosylated scFv bound specifically to the lectin domains of the MR and DC-SIGN and blocked signaling. Mannosylated scFv also bound to DC-SIGN on the surface of dendritic cells. This unique lymphoma-specific interaction of sIg with lectins of innate immunity reveals a potential route for microenvironmental support of tumor cells, mediated via the key B-cell receptor.
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B cell | B-cell receptor | B-cell lymphoma | immunoglobulin F ollicular lymphoma (FL) generally develops from B cells that have undergone the t(14;18) translocation, up-regulating expression of the BCL-2 oncoprotein (1). Although the translocation disrupts one Ig allele, expression of surface Ig (sIg) is retained, suggesting a role for sIg in tumor cell behavior. Interestingly, normal subjects can have B cells with the characteristic translocation (2) , and cells with features of "precursor" cells have been detected, especially after exposure to environmental toxins (3) . These observations suggest a multistep route to lymphomagenesis.
One potential step was revealed by our finding that the variable region genes of the Ig in FL have accumulated acceptor sequence motifs for addition of N-glycans (4). These sequence motifs are introduced during somatic hypermutation and are characteristic only of FL and some germinal center tumors, being very infrequent in normal B cells, in chronic lymphocytic leukemia, or in myeloma (5) . The frequency of motifs in FL-derived IGHV sequences deposited in the database was 55 of 70 (79%), as compared with 7 of 75 (9%) in normal somatically mutated B cells (4). This high incidence was confirmed in a study of FL cases entered into a clinical trial, in which 24 of 24 cases had motifs (6) . Because both studies were confined to IGHV, but it is now known that motifs can be found in IGLV (7) , this indicates that the overall incidence in FL may approach 100%.
Another finding was that the glycans added to the motifs were unusual in terminating at high mannose, a feature generally confined to "immature" glycoproteins in the endoplasmic reticulum. Most surface glycoproteins, including the constant regions of normal Ig, mature through addition of further sugars during transit of the Ig through the Golgi stacks (8) . Expression of mannosylated proteins is therefore unexpected, and the fact that mannoses were located in the variable regions of the sIg strongly suggested that they could be influencing the behavior of FL cells. Our hypothesis (9) was that there was an opportunistic interaction between the Bcell receptor of FL cells with a mannose-binding lectin in the germinal center where tumor cells are located. Interestingly, there is evidence for constitutive activation of FL cells in vivo (10) .
The observations that genes primarily associated with monocytes and dendritic cells (DCs) are predictive of a poorer outcome in FL (11) , and that higher numbers of CD68 + macrophages are associated with a poorer prognosis (12) , reveal candidate cells for this interaction. Importantly, macrophages located both within and between the follicles seem to be predictors of disease progression (13) . The activation status of tumor-associated macrophages may also be critical, with Stat-1 expression, essential for IFNγ signaling, an apparently adverse prognostic factor (14) . Although prognosis is complicated by combining pathogenesis with response to therapy, these findings place FL-associated macrophages in line with other tumor-associated macrophages that have been shown to promote tumor progression (15) by multiple pathways, possibly including suppression of immune responses (16) .
Candidate molecules for interaction with mannosylated Ig include C-type lectins that bind carbohydrate structures in a Ca 2+ -dependent manner. C-type lectins act as pattern recognition receptors (17) , able to bind to pathogens and activate immunity (18) . They also bind to endogenous ligands and mediate cell-cell interactions during immune responses (18) . Two major C-type lectins with specificity for high mannose structures are the mannose receptor (MR) and DC-SIGN (DC-specific intercellular adhesion molecule-3-grabbing nonintegrin) expressed by cells of innate immunity, including macrophages and DCs (19) .
We have now demonstrated that binding of mannose-binding lectins to FL triggers B-cell receptor-mediated signaling events, thereby establishing a functional connection between primary lymphoma cells and the innate immune system. Conversely, mannosylated Ig derivatives can bind to specific lectins on DCs. This functional bridge to the key B-cell receptor in FL could replace the need for antigen to promote survival of B cells in the germinal center.
Results
Surface IgM of Primary Lymphoma Cells Expresses Mannosylated IgM.
The first question was whether primary lymphoma cells expressed mannosylated IgM at the cell surface. We therefore investigated primary lymphoma cells directly, randomly selecting two FL cases known to have mannosylated N-glycosylation motifs in the Ig variable regions (7) . Biotinylation was used to label and isolate the sIgM, and this was exposed to specific glycosidases, Endo-H and peptide:N-glycosidase (PNGase), which cleave either mannosylated or all N-glycans, respectively. Although both FL and normal B cells carry mature PNGase-cleavable glycans at sites in the constant regions, the pattern of Endo-H cleavage of the biotinylated sIgM shows clearly that the FL cases, but not normal B cells, carry additional mannosylated glycans (Fig. 1) . Endo-H cleavage of mannosylated glycans of sIgM increased mobility on the gel in both cases, with a greater effect in case FL21 as compared with FL29 (Fig. 1) . PNGase removed all glycans from FL cell samples and from normal B cells, leading to μ chains of ≈70 kDa. An estimate of Endo-H susceptible sites can be made by measuring the migration distance after treatment as a proportion of the change due to PNGase. For FL29, with two sites in the μ chain, this was 31%, whereas for FL21, with four sites, this was 50%. It seems therefore that the mannosylation of the Ig variable regions of FL cells occurs in vivo. This validates the findings of mannosylated sites in lymphoma-derived Ig expressed by heterohybridization, analysis of which had located mannosylation to the Ig variable region (9) . It also indicates that single-chain Fv (scFv) expressed in human cells provides a faithful reproduction of the natural glycosylation pattern in vitro. Using this expression system, we detected mannosylation in seven of seven randomly selected cases of FL (7).
Mannosylated Ig and scFv Bind to C-Type Lectins in Vitro. To assess the potential functional importance of the mannosylated sIg, we tested the ability of mannosylated scFv or of whole Ig derived from cases of FL to bind to recombinant lectins. As controls we used nonmannosylated scFvs, or purified whole monoclonal IgG, derived from cases of multiple myeloma (MM), which do not have Nglycosylation sites in the variable regions (7) . The MR consists of multiple functional domains, and these were expressed either as the C-type lectin-like domains (CTLD) 4-7, comprising the mannose-binding domain (CTDL 4), or, as a control, CR-FNII-CTLD 1-3, comprising the cysteine-rich domain, the fibronectin type II domain, and CTLDs 1-3 ( Fig. S1 ). These were designated as Lectin-MR and Control-MR, respectively. DC-SIGN is a type II transmembrane protein. The extracellular domain of this lectin consists of a series of tandem repeats of 23 amino acids followed by a C-type carbohydrate recognition domain. The recombinant DC-SIGN-Fc available was expressed as the extracellular portion (amino acid residues 64-404). Each recombinant lectin is fused to human Fcγ for detection and purification. Using scFv-Cκ molecules derived from the two cases of FL above, together with seven further randomly selected cases with one to five glycosylation sites (V H and V L ), we found that all showed Ca 2+ -dependent binding of Lectin-MR and of DC-SIGN, with insignificant binding of Control-MR (Fig. S2i ). In the absence of any lectin there was no detectable binding signal; therefore, the very low level of binding of the Control-MR indicates a minor interactive ability with the scFv molecules, more evident in the MM-derived nonmannosylated scFvs, where there was no significant specific lectin binding (Fig.  S2i ). There was variability in the relative binding capacity of the various mannosylated scFv molecules for Lectin-MR and DC-SIGN. A similar variable but specific pattern was obtained using whole IgG derived from three additional FL cases by heterohybridization, with no specific binding of a control IgG myelomaderived protein (Fig. S2ii) . These data confirm the biochemical data (7, 9) showing that FL-derived Ig from a range of patients, expressed in two molecular forms, and in different mammalian expression systems, are mannosylated, and reveal that mannoses are exposed in a configuration that allows binding to the lectins. Fig. 2 A and B) . Binding of the Control-MR, particularly evident for FL21, seemed to be at least partly Ca 2+ independent and presumably represents binding by the cysteine-rich domain, which has specificity for sulfated glycans (20) .
Surprisingly, Ca 2+ -dependent binding by Lectin-MR and DC-SIGN also occurred to normal human B cells, which do not carry mannosylated sites in sIgM (Fig. 2C) . There was some binding of the Control-MR to normal B cells, which seemed to be largely Ca 2+ independent. The pattern of lectin and control binding to normal B cells was similar to FL cells, except that mean fluorescence intensity (MFI) for both lectins was lower than for the FL cases. For FL, the major question was whether the outcome Viable normal B cells were purified by negative selection from PBMCs. Cellsurface proteins were isolated from each sample and treated with Endo H or PNGase as indicated. Changes of μ chain mobility after enzyme treatment were analyzed by immunoblotting using an anti-μ antibody. Reproducibility was assessed by repeating the immunoblotting three times with similar results. (21) . We found that polyclonal F(ab′) 2 anti-μ antibody led to a Ca 2+ flux in FL29 cells, as expected ( Fig. 3 Ai and Aii). However, the striking finding was that lectins were also able to mediate signals in FL cells, with Lectin-MR (Fig. 3Ai) and DC-SIGN (Fig. 3Aii) each generating a Ca 2+ flux. For both lectins, the signal was weaker and slower than that induced by anti-μ, possibly owing to binding of the polyclonal anti-μ to multiple sites on sIgM. However, the response to Lectin-MR could be amplified by prior cross-linkage using anti-Fcγ (Fig. 3Ai) , with higher numbers of responding cells and a faster response. The effect of cross-linkage on DC-SIGN was less evident, with only a modest increase in rate of response observed (Fig. 3Aii) . This lesser dependence of signaling efficacy on cross-linkage via Fcγ could reflect the natural ability of DC-SIGN to form tetramers via the neck region of the molecule (22) . No effect was seen using the cross-linked Control-MR (Fig. 3Ai) . It seems that, although the lectin domains can presumably dimerize via the fused human Fcγ portion, multimerization increases the rate and level of the specific signal, at least for Lectin-MR. Confirmation of the ability of cross-linked Lectin-MR and DC-SIGN to induce a Ca 2+ signal in FL cells was obtained using FL21 (Fig. 3Aiii) and was confirmed in four of four additional FL cases (Fig. S3) .
For Lectin-MR, signaling in FL29 was completely blocked by preincubation with the homologous FL-derived mannosylated scFv at a molar ratio of scFv:Lectin-MR of 2:1, but not by nonmannosylated scFv (Fig. 3Bi) , indicating that, for this lectin, Ig-derived mannosylated scFv was a strong competitor for the cell-surface target. DC-SIGN-induced signaling was considerably but not totally blocked by mannosylated scFv (Fig. 3Bii) at a molar ratio of scFv:DC-SIGN of 7:1, and inhibition could not be increased significantly by raising this to 15:1. The requirement for higher levels of scFv for blocking could again reflect the multimeric nature of the recombinant DC-SIGN, which would confer a high avidity for the cell surface IgM. An alternative possibility is that DC-SIGN may be capable of mediating an additional weaker signal in FL cells, possibly unrelated to its lectin domain. Although ligands for the non-CTLD domains of DC-SIGN are known (23), most investigators have studied back signaling into the DC rather than into a target cell; therefore, this observation needs further investigation. SIGN) . (C) Normal B cells purified from (i) subject 1 exposed to anti-μ or to X-Lectin MR; (ii) subject 2 exposed to anti-μ or to X-DC-SIGN; (iii) PBMCs from subject 3 exposed to anti-μ or to X-Lectin-MR or to X-DC-SIGN. In all cases, anti-μ was F(ab) 2 .
For normal blood B cells from two subjects (1 and 2) , the response to anti-μ was strong and similar to that in the FL cells ( Fig. 3 Ci and Cii). The effect of cross-linked lectins on normal B cells was then investigated, using the same conditions as for FL cells. No lectin-mediated signaling was detectable in normal B cells, with cross-linked Lectin-MR failing to generate any detectable signal (Fig. 3Ci) . The second normal donor was tested with cross-linked DC-SIGN, which also was completely negative (Fig. 3Cii) . This donor was found to have 41.8% of CD27-positive B cells within the CD19-positive population, therefore the failure to signal indicates that neither naïve nor memory B cells responded to Lectin-MR. A further normal donor was tested using unselected peripheral blood mononuclear cells (PBMCs), locating B cells by FACS with anti-CD19. Although B-cell numbers were low, again a response to anti-μ and no response to either lectin were observed (Fig. 3Ciii) . The discriminatory outcome indicates that lectin interaction with mannosylated sites can distinguish between FL cells and normal cells, whereas anti-μ cannot. Evidently, binding to the non-Ig receptors on the surface of normal B cells (and presumably on FL cells) occurs (Fig. 2) , but only the binding to the mannosylated sIgM and not to nonmannosylated sIgM or to other cell-surface molecules, leads to signaling.
To directly locate the binding of the lectins to the sIgM of the FL cells, we investigated the ability of the bound cross-linked lectins to inhibit subsequent binding of anti-μ. For FL29, the expression of sIgM indicated two populations (Fig. 4Ai) , but staining for BCL-2 was positive for both; therefore, all of the sIgM-positive cells seem to be FL cells. Blocking was evident and equivalent using either Lectin-MR or DC-SIGN (Fig. 4Ai) . For FL21, where sIgM expression was again heterogeneous, blocking was seen with both lectins but seemed more efficient with DC-SIGN (Fig. 4Aii) . In both cases, no blocking was detected using Control-MR. To ensure that the cross-linked lectins bound to the cell surface were not inhibiting access of antibodies against other cell-surface molecules nonspecifically, the effect of lectins on binding of anti-CD19 was assessed. No effect was observed (Fig. 4 Aiii and Aiv) for either FL case. The ability of the lectins to at least partially block binding of the polyclonal anti-μ to sIgM, even though the binding sites differ, locates lectin binding to sIgM.
The next question concerned the effect of lectins on binding of anti-μ to normal B cells. Normal sIgM-positive B cells in blood comprise naïve and memory B cells, with the latter expressing higher levels of sIgM (24, 25) . No effect of lectin exposure on the access of anti-μ to the total IgM + B-cell population in blood was detected (Fig. 4Bi) . Because FL cells resemble memory B cells more closely than naïve B cells, we also specifically investigated CD27 + memory B cells. These cells express more sIgM, but again no lectin-mediated blocking of anti-μ was detectable (Fig. 4Bii) . It seems that lectins bound to sIgM in FL cases are able to block access of anti-μ, but lectins bound to other cell-surface molecules on normal B cells cannot. These results support the conclusion that there is FL-specific lectin-mediated signaling via sIgM.
Dendritic Cells Bind to Mannosylated scFv via Specific Receptors. To determine whether cell surface-expressed lectins can recognize mannosylated Ig, mannosylated scFv probes derived from FL or nonmannosylated scFvs were used. Dendritic cells were generated from monocytes in vitro. Mannosylated scFvs from two patients showed Ca 2+ -dependent binding to DC, with no binding of nonmannosylated scFvs (Fig. 5A) . Knockdown of DC-SIGN expression by the DCs was achieved using specific siRNA, shown by reduction (69%) of mRNA levels, with no effect on mRNA from the MR (Fig. S4i) . Protein expression of DC-SIGN was partially reduced, again without affecting expression of MR (Fig.  S4ii) . By gating on the knocked-down population of DCs (R1 gate, Fig. S4ii) , it was possible to analyze the level of binding of mannosylated scFvs to DC-SIGN.
For both FL cases, binding of the derived mannosylated scFv in DCs with reduced DC-SIGN expression was less than that to cells treated with control siRNA (Fig. 5 Bi and Bii). However, some binding ability remained, possibly due to MR or to other receptors. It was not possible to knock down MR specifically using currently available siRNA. The conclusion is therefore that mannosylated scFv clearly binds to DC-SIGN on DCs, but the question of involvement of other receptors remains open.
Discussion
Development of FL is known to require more than the t(14;18) translocation, assumed to have occurred in the bone marrow. We propose that another step in the evolution of lymphoma occurs as the prelymphoma cell differentiates and involves the acquisition of N-glycosylation sites during somatic mutation (Fig. S5) . Retention of the introduced glycan addition sites by FL cells over time of disease supports this concept (7) . Added sugars are unusual in terminating at high mannose, normally a biosynthetic precursor glycoform in the endoplasmic reticulum.
The previous finding that whole Ig expressed from FL cells by heterohybridization has mannosylated sites in the variable regions but has fully N-glycosylated sites in the constant region (9) indicates steric influences on accessibility of the IgM domains to glycosyltransferases in the Golgi stacks. This is perhaps more likely than an influence of adjacent primary V-gene sequences, especially because this varies with the V gene involved and with somatic + cells was used to indicate no effect of lectins on sIgM expression by memory B cells. Reproducibility was assessed by repeating the blocking assay three times with similar results. The total number of N-glycosylation sites (GLY) in the IGHV and IGLV genes of each case is indicated. mutational changes. One study of an unusual mouse monoclonal anti-dextran antibody reported addition of complex mature glycans at a natural site in the CDR2 of VH but mannosylation at an introduced site nearby. Importantly the same pattern of glycosylation occurred using several expression systems, indicating an intrinsic structural feature (26) . Our studies, using two expression systems and two molecular forms of FL-derived Ig, support this consistency, with glycan composition verified by susceptibility to Endo-H enzyme and by sugar analysis (7).
However, it was important to identify mannosylated sIgM on primary FL cells, and this is now clear. Its functional role is indicated by identifying a unique lectin-mediated signaling pathway operating on the FL B-cell receptor but not on normal B cells. This discriminatory signal could release the transformed B cells from dependence on antigen for growth or survival in the hostile environment of the germinal center.
There is a forest of glycoproteins expressed at cell surfaces, with different N-glycan patterns, although termination at high mannose is rare. Glycans have many functions, including the cell-cell interactions required for adhesion and migration (18) . Clearly a wide range of lectins can bind to multiple glycans expressed on the cell surface of both FL and of normal B cells. Binding of C-type lectins to normal human B cells has been reported previously using mannose-binding lectin as a probe (27) , and binding of DC-SIGN is apparently increased in cells of B-lineage acute lymphoblastic leukemia (28) . However, lectins are rarely completely specific for particular sugars, and it is unclear which oligosaccharides were responsible for lectin binding to these B cells or what the functional significance is.
Certainly, binding per se does not mediate signaling to the B cell, as measured by Ca 2+ flux. It seems that only if the lectin binds specifically to the mannosylated sIg of the B-cell receptor can a signal be generated. This is in contrast to the comparable signal detected in both normal and neoplastic B cells when sIg is engaged by anti-μ. A previous study of FL reported that anti-Ig induced phosphorylation of Btk, Syk, and p38 even more effectively than in the infiltrating nontumor B cells (29) . We did not observe a weaker signaling in normal B cells compared with FL cells, and this differential may be confined to intratumoral normal B cells (29) . The critical point is that whereas both FL and normal B cells, of naïve or memory type, can respond to engagement of sIg with anti-Ig, only FL cells, which bear mannoses in the variable region of the Ig, respond to lectins. However, normal B cells are highly heterogeneous, and it would be expected that motifs would be generated at some level during somatic mutation. Analysis of centroblasts/centrocytes in a reactive lymph node would be useful to investigate this point. The question is whether antigen selection would act against accumulation of these cells in the memory pool. A small percentage of B cells clearly acquires N-glycosylation sites in IGHV genes, and in an unusual example, the presence of glycan increased the affinity of a mouse monoclonal antibody for a carbohydrate dextran antigen (30) . However, few motifs are found in the human memory B-cell population, indicating that, in contrast to FL cells, this feature is rarely positively selected.
The nature of the partner lectin-expressing cell is not yet known, and identification will require exploration of cell-cell interactions in vitro and detailed probing of candidates in FL tissues. Among the candidate lectin-expressing cells in FL are macrophages, known to be associated with a shorter survival (12, 31) , and DCs, implicated in prognosis by gene expression profiling (32). Both express lectins able to signal FL cells, potentially creating a functional bridge between the key sIg receptor, retained and mannosylated in the vast majority of FL cases, and a microenvironmental cell-bound lectin.
In terms of lymphomagenesis, a multistep pathway is likely, with the t(14;18) translocation as the first step. It seems that transformed cells can respond to antigen and establish a germinal center (33) , where somatic mutation, documented to occur after transformation from intraclonal variation in FL V-gene sequences, takes place (Fig. S5) . Acquisition of N-glycans would be another step in lymphomagenesis, because tumor cells retained in the hostile germinal center, with dwindling antigen levels, could obtain antigen-independent support via interaction of mannosylated sIg with adjacent lectins. This opportunistic strategy may exploit the microenvironment for growth and survival of tumor cells (Fig. S5) . Clearly cell-cell interactions must be analyzed, but we are concerned that FL-derived cell lines may not retain glycosylation patterns characteristic of cells in vivo, making primary lymphoma the only feasible target for investigation and therefore limiting the investigational scope.
The clinical relevance is that interruption of this interaction could be beneficial for patients, even though the partner cells involved remain unknown. It is possible that the efficacy of antiidiotypic antibody (34) depended at least in part on blocking this vital interaction. However, rather than individual antiidiotypic antibodies being required, an antibody or small molecule capable of blocking a mannose-lectin interaction could provide a single therapy for FL targeting the same critical molecule, sIg.
Materials and Methods
Patient and Healthy Donor Material. Samples of primary cells from lymph nodes of two FL patients and PBMCs from healthy donors were isolated from frozen stocks (35) . Approval was obtained from the Southampton and South West Hampshire Research Ethics Committee. Informed consent was provided in accordance with the Declaration of Helsinki.
Biotinylation and Glycosylation Analysis of Cell Surface Proteins. Surface proteins of cells (>90% viability) were labeled with biotin (35) . Analysis of gly- cosylation patterns was performed by assessing susceptibility of the isolated surface proteins to Endo-H and PNgase (35) .
Recombinant Proteins. FL-derived scFv-Cκ proteins were assembled and expressed (7) . FL-derived complete Igs were generated via heterohybridomas (9) . Fc-chimeric proteins containing different regions of the mannose receptor (CR-FNII-CTDL1-3-Fc and CTDL4-7-Fc) were generated (36, 37) . DC-SIGN-Fc was purchased from R&D Systems. Recombinant lectins were cross-linked by 30-min incubation with a mouse monoclonal anti-human IgG, γ chain-specific (Southern Biotech) at a molar ratio of ≈1:1, at 4°C before the assay.
Analysis of Lectin Binding to Cells by Flow Cytometry. FL B cells or normal B cells were thawed, washed, and allowed to recover in medium for 1 h (35). Single-cell suspensions were left on ice in lectin buffer [10 mM Tris (pH 7.4), 154 mM NaCl, 3% BSA, 2 mM NaN 3, supplemented or not with 10 mM CaCl 2 ] for 45 min. Binding of recombinant lectins to the B cells was analyzed by adding lectin constructs (with or without cross-linkage) at saturating levels of 20 μg/mL and detected by a polyclonal anti-human Fcγ (Jackson ImmunoResearch) at 10 μg/mL. Simultaneously, B cells were also stained with anti-CD19APC or anti-CD27APC (both from Biolegend).
For analysis of binding to monocyte-derived DCs, differentiated cells were harvested from culture on day 6. Binding of the mannosylated and nonmannosylated scFvs to the DCs was tested by adding the scFvs at 15 μg/mL and detecting by an anti-Cκ light chain phycoerythrin antibody (Dako). All incubations and washing steps were performed in lectin buffer as above.
Measurement of Intracellular Ca

2+
. Calcium mobilization was measured using the fluorogenic probe Fluo 3-AM (38) . Cells were also stained with anti-CD19 APC labeled (Biolegend). Cells were stimulated with 10 μg/mL of either anti-μ or recombinant lectins and FL1 recorded over the next 5 min. To test blocking of lectin binding by scFvs, recombinant lectins were incubated with scFvs, at a molar ratio of scFv:DC-SIGN of 7:1 and scFv:Lectin-MR of 2:1, at 4°C for 30 min before stimulation. For these assays the DC-SIGN concentration was reduced to 5 μg/mL. Data were analyzed using FlowJo software.
Monocyte Differentiation and DC-SIGN Knockdown. To determine whether cell surface lectins expressed by immune cells can recognize mannosylated Ig, FLor MM-derived scFvs were used as tools. Immature DCs were generated from CD14 + monocytes obtained from healthy donors (39 
